Taylor K. Peabody
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Taylor K. Peabody has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Danielle S. Shpiner
Department of Neurology, University of Miami Leonard M. Miller School of Medicine, Miami, FL 33136, US
2 shared publications - Henry Moore
University of Miami Miller School of Medicine, Miami, FL 33136, USA
2 shared publications - Alberto Cruz1 shared publication
- Corneliu C. Luca
Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States
1 shared publication - Jonathan Russell Jagid
University of Miami Miller School of Medicine, 1600 NW 10th Avenue, Miami, Florida, 33136-1015, UNITED STATES
1 shared publication - Lucila Hernandez1 shared publication
Latest Publications
- Open Access
- 9 August 2025
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 13
Advance care planning in Hispanic populations with Parkinson’s Disease: Investigating disparities in end-of life care
- 9 August 2025
- Published by Elsevier in Clinical Parkinsonism & Related Disorders
- Vol. 13
Open AccessAdvance care planning in Hispanic populations with Parkinson’s Disease: Investigating disparities in end-of life care
- Open Access
- 30 October 2023
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 13 (1) , 40
Deep Brain Stimulation for an Unusual Presentation of Myoclonus Dystonia Associated with Russell-Silver Syndrome
Background: Myoclonus dystonia syndrome typically results from autosomal dominant mutations in the epsilon-sarcoglycan gene (SGCE) via the paternally expressed allele on chromosome 7q21. There is evidence that deep brain stimulation (DBS) is beneficial for this genotype, however, there are few prior case reports on DBS for myoclonus dystonia syndrome secondary to other confirmed genetic etiologies. Case Report: A 20-year-old female with concomitant Russell-Silver syndrome and myoclonus dystonia syndrome secondary to maternal uniparental disomy of chromosome 7 (mUPD7) presented for medically refractory symptoms. She underwent DBS surgery targeting the bilateral globus pallidus interna with positive effects that persisted 16 months post-procedure. Discussion: We present a patient with the mUPD7 genotype for myoclonus dystonia syndrome who exhibited a similar, if not superior, response to DBS when compared to patients with other genotypes. Highlights This report outlines the first described case of successful deep brain stimulation treatment for a rare genetic variant of myoclonus dystonia syndrome caused by uniparental disomy at chromosome 7. These findings may expand treatment options for patients with similar conditions.
- 30 October 2023
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 13 (1) , 40
Open AccessDeep Brain Stimulation for an Unusual Presentation of Myoclonus Dystonia Associated with Russell-Silver Syndrome
Background: Myoclonus dystonia syndrome typically results from autosomal dominant mutations in the epsilon-sarcoglycan gene (SGCE) via the paternally expressed allele on chromosome 7q21. There is evidence that deep brain stimulation (DBS) is beneficial for this genotype, however, there are few prior case reports on DBS for myoclonus dystonia syndrome secondary to other confirmed genetic etiologies. Case Report: A 20-year-old female with concomitant Russell-Silver syndrome and myoclonus dystonia syndrome secondary to maternal uniparental disomy of chromosome 7 (mUPD7) presented for medically refractory symptoms. She underwent DBS surgery targeting the bilateral globus pallidus interna with positive effects that persisted 16 months post-procedure. Discussion: We present a patient with the mUPD7 genotype for myoclonus dystonia syndrome who exhibited a similar, if not superior, response to DBS when compared to patients with other genotypes. Highlights This report outlines the first described case of successful deep brain stimulation treatment for a rare genetic variant of myoclonus dystonia syndrome caused by uniparental disomy at chromosome 7. These findings may expand treatment options for patients with similar conditions.